| Lightcalls.com |
|
|
![]() |
Ayurveda is a 6,000-year-old medici...Ayurveda is a 6,000-year-old medicine that is idea to be the earliest recorded theory developed by humankind to cope with illness. The word Ayurveda arrives from two Sanskrit words: Ayus, or "life," and Veda, which means "science" or "knowledge." The Ayurvedic "science of life" differs from traditional western health care in that western medicine approaches illness with cannons blasting -- an all-out frontal assault. at the same time oftentimes diplomacy is much better for the body; in these cases, Ayurveda skillfully negotiates a peace between the body's warring factions by means of gentle, yet powerful, persuasion. Combining herbal and other natural therapies with a "highly personalized approach to the treatment of disease," Ayurvedic medicine "places equal emphasis onward body, mind and spirit, and strives to restore the innate harmony of th individual," explains Alternative Medicine: The Definitive Guide. Dietary regimens and herbal approaches, as mentioned above, are lock opener components of Ayurveda, with fit digestion factoring in as an important goal. Daily and seasonal treatments are available which are designed to maintain optimum health based with your individual body type. Body signs fall under the Tridosha universal of Vata, Pitta and Kapha, the three basic psychosomatic, or metabolic, constitutions, determination of which is vital to accurate diagnosis and self-diagnosis. "This division into three constitutions makes feeling when we realize that, in Ayurveda, the human organism is first viewed as an inseparable whole before an examination of its organs and classifications takes place," suggests P. Vishwanath Rai, MD in Hans Rhymer's Ayurveda: The mild Health System. Why Ayurveda? With traditional western medicine, therapys and treatments for many illnesses remain elusive, "particularly those affecting the metabolism, systemic illnesses (affecting the whole organism), and psychosomatic illnesses," judges Rhymer. With modern-day Ayurveda, however -- enriched by dint of cutting-edge basic and clinical research -- many persons with seemingly intractable, chronic, underlying symptoms and conditions are giveed hope through very promising research in the following areas: protection from toxic substances, prevention of disease, and equal control of already-present disease processe (intervention). There are hardly any botanicals which offer as often hope as turmeric, a shut up relative of ginger known as Curcuma tonga in botany and as Haridra in Sanskrit. The long-established image of turmeric is as a vibrant-yellow-colored, chief ingredient of curried stew powder, as a natural commercial hue and as part of a example for the presence of alkalis. In fact, a great deal of excitement has been generated according to the discovery of phenolic mixs called curcuminoids, in the estate rhizome (rootlike stem) of turmeric, and their new definition, in 1995, as muscular bioprotectant agents by researcher Viadimir Badmaev, PhD MD and Muhammed Majeed, PhD The three main curcuminoids that were isolated from turmeric are: curcumin, demethoxy curcumin and bisdemethoxy curcumin. The "bioprotectant" issues of these compounds are best demonstrated within the results of original laboratory studies, which exhibit to that curcuminoids: prevent free radicals from forming in the first place and intervene at neutralizing the free radicals which have been already formed. Curcumin's antioxidative intermixs have been specifically shown to be: anti-atherosclerotic (anticoronary plaque), antimutagenic (anti-cancer), anti-inflammatory, anti-viral, antibacterial, antifungal and antiparasitic. A 1992 research (Indian Journal of Physiology and Pharmacology 36:273) on K.B. Soni and R. Kuttan lay the foundation of that daily administration of 500 mg of curcuminoids to healthy offers for seven days lowered blood-lipid peroxide of the same heights by 33 percent and total serum cholesterol evens by 29 percent, showing that these golden factors are potent antiatherosclerotic compounds In spells of protection from cancer, in an article by the agency of Chinthalapally V. Rao, et al., which appeared in Cancer Research (55:259-266 1995) colon cancer indicators were reduc according to between 38 to 50 percent in those animals which received curcumin in the diet at a concentration of 02 percent Curcumin's anti-inflammatory actions were revealed in a 1986 double-blind, controll meditation by R.R. Satoskar, et al., that appeared in the International Journal of Clinical Pharmacology, Therapy and Toxicology (24:651-654) In this thought the effect of a thrice-daily 400 mg dose of curcumin was examined in patients who were undergoing surgery Total inflammation was significantly reduc in those who received curcumin compared to those who did not. Other fascinating findings have been reported in the areas of AIDS [anti-viral action v HIV] (Li, 1993) harm healing (Gujral, M.L., 1953), ulcer-prevention (Sinha, 1975) liver-protection (Hikino, 1985) and others. Recent research indicates that a dose of 250 mg to 500 mg single to three times a day, of a naturally-occurring-antioxidative "curcuminoid complex" (which includes curcumin, bisdemethoxy curcumin and demethoxy curcumin) is superior to individual curcuminoids in prevention and intervention, therefore superior in bioprotectant action. |
![]() |
Other Articles
-Morphotek will collaborat...-Eksigent Technologies nam... -The benefits of outsourci... -Sartorius Corporation ... -In our previous column, w... -Efoora appointed Michael ... -Affymax appointed Anne-Ma... -Traditionally, continuous... -New Brunswick Scientific ... -The German-American firm ... -Don G. Burstyn, formerly ... -American patients are mor... -Summary Prior to va... -BioPharm Editorial Adviso... -Australia agreed to spend... -The Biotechnology Industr... -Ambion, The RNA Company i... -Therapies based on living... -A recent survey found tha... -ViroLogic will acquire Ac... -Cardinal Health named Joh... -One of the greatest chall... -As the president of a sma... -Sweden-based Biovitrum wi... -Nanogen appointed David L... -The Experion Process Know... -Although biomedical resea... -The Supreme Court of Cana... -Netherlands-based DSM Bio... -David A. Smoller joined S... -A few months ago, I wrote... -Panacos Pharmaceuticals w... -Karen K. Vaccaro will res... -Acceleron Pharma appointe... -Two quarterly meetings of... -Illinois-based Abbot Labo... -FKI Logistics announced t... -The following corrections... -It its widest definition,... -UK-based Xcellsyz will li... -Andrew P. Aromando joined... -Invitrogen's comprehensiv... -Last month, we described ... -The Swiss life sciences c... -Protein Design Labs (PDL)... -Model It HNMR, the newest... -Tech transfer, like chang... -QLT and Atrix Laboratorie... -Dendreon announced Christ... -Baxter Pharmaceutical Sol... -The biopharmaceutical ind... -GlaxoSmithKline announced... -Montreal-based Caprion Ph... -Xenova Group recently ann... -Cole-Parmer's new 192-pag... -Over the last decade ther... -Benchmark your facility p... -As biotechnology organiza... -Frederick D. Sancillo, fo... -Insmed acquired a recombi... -Baxter Pharmaceutical Sol... -Model It HNMR, the newest... -DA's regulation 21 CFR Pa... -Robert P. Ryan joined Ath... -A new report from Busines... -Biotest offers a complete... -Swagelok offers a brochur... -Partnering is a global ph... -Human Genome Sciences CEO... -Shorten the process devel... -The licensure of biotechn... -Rodger Currie joined Amge... -The GEA Filtration Model ... -A multi-channel chemistry... -From June 6-9, San Franci... -Skanska USA Building Inc.... -New Brunswick Scientific'... -AVI BioPharma appointed P... -Ambion, The RNA Company, ... -"If you want to be a... -Xcellerex appointed Susan... -Researchers identified th... -Cool Spring Business Park... -In October 2003, Shenzhen... -Laureate Pharma appointed... -After a 6-5 vote by Calif... -QSourcing, a service of Q... -The recent discovery of &... -Affymax added Douglas L. ... -USDA recently approved tw... -BioPharm International is... -Serologicals has released... -This document by Shenzhen... -Robert Bronstein joined A... -Gloucester Gains Fujisawa... -With more than 30 years o... -Pall's SUPRAdisc II depth... -In today's competitive ma... -Protein Design Labs repor... -Charles A. Rice will repl... -AstraZeneca's Faslodex (f... |
| . |